MTAP as an emerging biomarker in thoracic malignancies.
Brune MM, Savic Prince S, Vlajnic T, Chijioke O, Roma L, König D, Bubendorf L.
Lung Cancer. 2024 Nov;197:107963. doi: 10.1016/j.lungcan.2024.107963. Epub 2024 Sep 29.
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.
Zhang S, Wang W, Xu C, Zhang Y, Cai X, Wang Q, Song Z, Li Z, Yu J, Zhong W, Wang Z, Liu J, Liu A, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Lin G, Huang L, Yuan J, Jiang Z, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Zhou J, Zhu Z, Pan W, Dong X, Pang F, Wang K, Yao C, Lin G, Li S, Yang Z, Luo J, Jia H, Nie X, Wang L, Zhu Y, Hu X, Xie Y, Lin X, Cai J, Xia Y, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Kang J, Zhang J, Zhang C, Gao W, Huang J, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Wan B, Lv D, Yu G, Shi L, Xia Y, Gao F, Zhang X, Xu T, Zhou W, Wang H, Liu Z, Yang N, Wu L, Wang Q, Wang G, Hong Z, Wang J, Fang M, Fang Y, Zhang Y, Song Y, Ma S, Fang W, Lu Y.
Thorac Cancer. 2023 Jan;14(1):91-104. doi: 10.1111/1759-7714.14743. Epub 2022 Nov 28.
Outcomes after sublobar resection versus lobectomy in non-small cell carcinoma in situ.
Perez Holguin RA, Olecki EJ, Wong WG, Stahl KA, Go PH, Taylor MD, Reed MF, Shen C.
J Thorac Cardiovasc Surg. 2023 Mar;165(3):853-861.e3. doi: 10.1016/j.jtcvs.2022.05.032. Epub 2022 Jun 1.
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.
Lim RJ, Salehi-Rad R, Tran LM, Oh MS, Dumitras C, Crosson WP, Li R, Patel TS, Man S, Yean CE, Abascal J, Huang Z, Ong SL, Krysan K, Dubinett SM, Liu B.
Cell Rep Med. 2024 Apr 16;5(4):101479. doi: 10.1016/j.xcrm.2024.101479. Epub 2024 Mar 21.
Diagnosis and Treatment of Three Cases of Bronchial Carcinoma In Situ.
Andreev VY, Yanev NA, Stanimirov SK, Mircheva TV, Ivanov IN, Popovska S, Hristova PA, Ivanov YY.
Folia Med (Plovdiv). 2018 Mar 1;60(1):164-169. doi: 10.1515/folmed-2017-0062.
Outcome of bronchial carcinoma in situ.
Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja TG.
Chest. 2000 Jun;117(6):1572-6. doi: 10.1378/chest.117.6.1572.
LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y, Jiang X, Duan L, Xiong Q, Yuan Y, Liu P, Jiang L, Shen Q, Zhao S, Yang C, Chen Y.
Mol Cancer. 2021 Dec 2;20(1):156. doi: 10.1186/s12943-021-01469-6.
The natural history of carcinoma in situ involving bronchial resection margins.
Pasic A, Grünberg K, Mooi WJ, Paul MA, Postmus PE, Sutedja TG.
Chest. 2005 Sep;128(3):1736-41. doi: 10.1378/chest.128.3.1736.
Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer.
Yu H, Magoulopoulou A, Amini RM, Chatzinikolaou MP, Horie M, Lindberg A, Mezheyeuski A, Backman M, Metousis A, Brunnström H, Marincevic M, Botling J, Mattsson JSM, Kärre K, Leandersson K, Nilsson M, Strell C, Micke P.
J Immunother Cancer. 2025 Aug 27;13(8):e012089. doi: 10.1136/jitc-2025-012089.
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.
Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K.
J Clin Oncol. 2018 May 10;36(14):1405-1411. doi: 10.1200/JCO.2017.75.5587. Epub 2018 Mar 29.
